What Is Ciliary Neurotrophic Factor? Definition and What Research Reports
Ciliary neurotrophic factor (CNTF) is a naturally occurring protein classed as a neurotrophic cytokine in the interleukin-6 family. It is produced mainly by glial cells in the nervous system, and has also been detected in non-neural tissues. In research settings, CNTF and engineered CNTF analogues are used as laboratory tools in studies of retinal neurons, metabolism, cardiac tissue and stress biology, and CNTF concentrations have been measured as candidate biomarkers. This page is a definitional glossary entry summarising what published literature reports.
Plain-language definition
Ciliary neurotrophic factor (CNTF) is a naturally occurring protein — a neurotrophic cytokine — that was originally identified for its ability to support the survival of nerve cells in culture, and that is now studied across neuroscience, ophthalmology, metabolism and cardiovascular biology. It is not a short synthetic peptide of the kind most often catalogued in peptide glossaries; it is a full-length polypeptide roughly 200 amino acids long, and it belongs to the interleukin-6 (IL-6) family of cytokines, which signal through receptor complexes that include the shared subunit gp130. In the published literature the abbreviation "CNTF" is used both for the endogenous human or rodent protein and, loosely, for engineered derivatives such as CNTF analogues and PEGylated "superagonist" variants that laboratories construct to alter potency or circulating half-life.
What class of molecule is it, and where does it come from?
CNTF is classified as a cytokine with neurotrophic activity. Unlike classical secreted growth factors, the native protein lacks a conventional signal sequence, and it is generally described as being held in the cytoplasm of supporting cells and released in the context of injury. Its principal cellular sources are glial cells of the nervous system — astrocytes in the central nervous system and Schwann cells in peripheral nerve — and the protein has also been measured in blood serum and in other body fluids in human studies. Beyond the nervous system, CNTF-related signalling has been examined in tissues that are not usually thought of as neural: researchers have studied CNTF in human placental tissue in the context of matrix metalloprotease regulation and placental development (PMID 35794391), in fat cells derived from human multipotent adipose-derived stem cells (PMID 31781039), and in corneal tissue in a murine model (PMID 36755405).
Related terms
| Term | How it is used in the literature |
|---|---|
| CNTF | The endogenous protein itself, or recombinant protein used in experiments |
| CNTF analogue | A modified version of the protein engineered for research or therapeutic testing (PMID 28177690) |
| PEGylated CNTF superagonist variant | A polyethylene-glycol-conjugated variant designed for altered pharmacokinetics, tested in obesity models (PMID 35316287) |
| CNTF overexpression | A genetic approach in which tissue is engineered to produce more CNTF (PMID 33588234) |
How the term is used in peptide and protein research
Within the broader "peptides and proteins" research vocabulary, CNTF appears in three distinct ways. First, as an experimental agent: recombinant CNTF, CNTF analogues or CNTF-secreting constructs are applied to cells, scaffolds or animals to see what the protein does to a tissue. Second, as a measured biomarker: clinical investigators quantify CNTF concentrations in serum or other fluids and compare groups. Third, as a signalling pathway label, where "CNTF signalling" describes downstream events attributed to the CNTF receptor complex. Readers encountering the term in a study abstract should note which of these three usages applies, because the conclusions are not interchangeable — a study measuring serum CNTF in people is answering a different question than a study delivering CNTF to a mouse retina.
Doing the math on a vial? The PeptideU app does reconstitution, units and dilution for you.
Try it freeWhat the published literature reports
Retina and neural tissue
Retinal work has been among the most active areas. In a 2022 report, researchers described CNTF-mediated neuroprotection in degenerating mouse retinas as involving enhanced glycolysis and anabolism in retinal tissue (PMID 36396639). A separate 2024 tissue-engineering study reported that CNTF supported the growth of retinal ganglion cell axons on poly(glycerol sebacate)/poly(caprolactone) (PGS/PCL) scaffolds (PMID 38181445). At the ocular surface, a murine inhalation-toxicology study examined how vanadium exposure affected corneal CNTF (PMID 36755405).
Metabolism and adipose tissue
CNTF's metabolic actions have been studied both in cells and in animals. In vitro, the study of hMADS adipocytes characterised the biological effects of CNTF on human adipose-derived fat cells (PMID 31781039). In vivo, researchers evaluated the efficacy of a PEGylated CNTF superagonist variant in diet-induced obesity mice (PMID 35316287). These reports are preclinical; they describe what happened in cultured human fat cells and in mouse models rather than in humans.
Cardiac tissue
Two cardiovascular papers appear in the literature summarised here. A 2021 study reported that CNTF overexpression protected the heart against pathological remodelling in angiotensin II-infused mice (PMID 33588234). A 2025 study reported that CNTF attenuated myocardial infarction-induced oxidative stress and ferroptosis, with the authors attributing the effect to PI3K/Akt signalling (PMID 39954087).
Stress biology and central nervous system circuits
A 2022 paper in Neurobiology of Stress reported a female-specific role for ciliary neurotrophic factor in the medial amygdala in promoting stress responses (PMID 35146079), an example of CNTF being studied as an endogenous signalling molecule within a defined brain region rather than as an administered agent.
CNTF as a measured biomarker in people
Human studies in this set measured CNTF concentrations rather than administering it. Investigators measured serum ciliary neurotrophic factor levels in children with attention deficit hyperactivity disorder and compared them with controls (PMID 35815398). A separate group reported increased CNTF in blood serum and lacrimal fluid and discussed these as potential biomarkers of focal epilepsy (PMID 34031798). Biomarker associations of this kind describe correlation within the populations studied; they do not establish that CNTF causes the condition or that changing CNTF would change the condition.
Safety signals in animal research: What Studies Report
Not every reported CNTF finding is favourable. In a 2017 rat study, researchers reported that a ciliary neurotrophic factor analogue aggravated carbon tetrachloride (CCl4)-induced acute hepatic injury (PMID 28177690). That report is a reminder that a molecule described as protective in one tissue model — such as retina (PMID 36396639) or heart (PMID 33588234) — may behave differently in another organ and under a different injury model. No human safety dataset is described on this page, and no dosing information is provided here because the verified literature summarised above is defined by its reported models and outcomes rather than by protocols applicable to people.
Tracking research? Log entries with dates, lots and notes — records, never plans.
Get the appHow to read CNTF papers critically
- Check the species and model. Mouse retina, rat liver injury, angiotensin II-infused mice and cultured human adipocytes are not interchangeable systems.
- Check whether CNTF was administered, overexpressed, or merely measured. Overexpression studies (PMID 33588234) and serum-biomarker studies (PMID 34031798) answer different questions.
- Check whether the molecule was native CNTF or an engineered variant. Analogues and PEGylated variants (PMID 35316287) differ from the endogenous protein.
- Note contradictory directions of effect across organs, as in the hepatic injury report (PMID 28177690).
Regulatory status in brief
CNTF and CNTF analogues appear in the literature as laboratory and preclinical research materials. Recombinant proteins of this type are commonly distributed for research use only (RUO), a designation meaning the material is not intended for diagnostic or therapeutic use in humans. This page is for educational purposes only and is not medical advice; consult a licensed physician for any question about health, diagnosis or treatment.
Want the full course? Every compound, evidence-graded and cited, inside PeptideU.
Start learning freeReferences
- Serum ciliary neurotrophic factor levels in children with attention deficit hyperactivity disorder (The International Journal of Neuroscience, 2024)
- Ciliary neurotrophic factor analogue aggravates CCl4-induced acute hepatic injury in rats (Canadian Journal of Physiology and Pharmacology, 2017)
- Biological Effects of Ciliary Neurotrophic Factor on hMADS Adipocytes (Frontiers in Endocrinology, 2019)
- Ciliary neurotrophic factor mediated growth of retinal ganglion cell axons on PGS/PCL scaffolds (Biomedical Materials, 2024)
- Female-specific role of ciliary neurotrophic factor in the medial amygdala in promoting stress responses (Neurobiology of Stress, 2022)
- Modulation of matrix metalloproteases by ciliary neurotrophic factor in human placental development (Cell and Tissue Research, 2022)
- Ciliary neurotrophic factor overexpression protects the heart against pathological remodelling in angiotensin II-infused mice (Biochemical and Biophysical Research Communications, 2021)
- Ciliary neurotrophic factor-mediated neuroprotection involves enhanced glycolysis and anabolism in degenerating mouse retinas (Nature Communications, 2022)
- Ciliary neurotrophic factor attenuates myocardial infarction-induced oxidative stress and ferroptosis via PI3K/Akt signaling (Journal of Molecular Histology, 2025)
- Increased ciliary neurotrophic factor in blood serum and lacrimal fluid as a potential biomarkers of focal epilepsy (Neurological Sciences, 2022)
- Vanadium inhalation effects on the corneal ciliary neurotrophic factor (CNTF): study in a murine model (Cutaneous and Ocular Toxicology, 2023)
- Efficacy of PEGylated ciliary neurotrophic factor superagonist variant in diet-induced obesity mice (PLoS One, 2022)
Frequently asked questions
Is ciliary neurotrophic factor a peptide or a protein?▾
CNTF is best described as a protein — a neurotrophic cytokine of roughly 200 amino acids in the interleukin-6 family — rather than a short synthetic peptide. It is catalogued alongside peptides because it is a polypeptide research material, and because engineered derivatives such as analogues and PEGylated superagonist variants are studied in animal models (PMID 35316287).Cet class distinction matters when comparing studies.
Where in the body is CNTF produced?▾
CNTF is chiefly associated with glial cells of the nervous system, including astrocytes and Schwann cells. It has also been examined outside neural tissue: researchers studied CNTF in relation to matrix metalloproteases in human placental development (PMID 35794391), in human adipose-derived stem cell adipocytes (PMID 31781039), and in corneal tissue in a murine model (PMID 36755405).
What have retinal studies reported about CNTF?▾
A 2022 report described CNTF-mediated neuroprotection in degenerating mouse retinas as involving enhanced glycolysis and anabolism (PMID 36396639). A 2024 tissue-engineering study reported that CNTF supported growth of retinal ganglion cell axons on PGS/PCL scaffolds (PMID 38181445). Both are laboratory and animal findings, and neither describes outcomes in human patients.
Has CNTF been measured in people?▾
Yes, as a measured biomarker rather than as an administered agent in the studies summarised here. Investigators measured serum ciliary neurotrophic factor levels in children with attention deficit hyperactivity disorder (PMID 35815398), and another group reported increased CNTF in blood serum and lacrimal fluid, discussing it as a potential biomarker of focal epilepsy (PMID 34031798).
Have any negative findings been reported for CNTF?▾
Yes. In a 2017 rat study, researchers reported that a ciliary neurotrophic factor analogue aggravated carbon tetrachloride-induced acute hepatic injury (PMID 28177690). That contrasts with protective directions reported in cardiac models, such as CNTF overexpression protecting against pathological remodelling in angiotensin II-infused mice (PMID 33588234), which illustrates that effects reported vary by tissue and model.
What is a PEGylated CNTF superagonist variant?▾
It is an engineered derivative of CNTF conjugated to polyethylene glycol and modified for greater receptor potency, created so researchers can alter how long the molecule persists in circulation. A 2022 study evaluated the efficacy of such a variant in diet-induced obesity mice (PMID 35316287). It is a research construct, distinct from the endogenous human protein.
Does CNTF have a role in stress or brain circuits?▾
One 2022 study reported a female-specific role for ciliary neurotrophic factor in the medial amygdala in promoting stress responses (PMID 35146079). In that work CNTF was studied as an endogenous signalling molecule within a defined brain region. Findings of this kind describe a biological role in an animal model and do not translate directly to human behaviour or clinical outcomes.
Track it. Calculate it. Actually understand it.
References
This page summarises published research for education — it is not medical advice, and nothing here is a recommendation to use, purchase, or dose any substance. Study parameters described are what researchers reported, not instructions. Consult a qualified clinician before any health decision.